Early Stage HER2+ Breast Cancer
Also known as: HER2-Positive Early Breast Cancer / HER2-positive early-stage breast cancer / HER2-Positive Early Stage Breast Cancer / HER2 Positive Early Breast Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00072 | Trastuzumab | A monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. |
| DB05773 | Trastuzumab emtansine | An antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer. |